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Abstract. 
 
Bcl-2 family members either promote or re-
press programmed cell death. Bax, a death-promoting 
member, is a pore-forming, mitochondria-associated 
protein whose mechanism of action is still unknown. 
During apoptosis, cytochrome C is released from the 
mitochondria into the cytosol where it binds to APAF-1, 
a mammalian homologue of Ced-4, and participates in 
the activation of caspases. The release of cytochrome
C has been postulated to be a consequence of the open-
ing of the mitochondrial permeability transition pore 
(PTP). We now report that Bax is sufficient to trigger 
the release of cytochrome C from isolated mitochon-
dria. This pathway is distinct from the previously de-
scribed calcium-inducible, cyclosporin A–sensitive 
PTP. Rather, the cytochrome C release induced by Bax 
 
is facilitated by Mg
 
2
 
1
 
 and cannot be blocked by PTP in-
hibitors. These results strongly suggest the existence of 
two distinct mechanisms leading to cytochrome C re-
lease: one stimulated by calcium and inhibited by cy-
closporin A, the other Bax dependent, Mg
 
2
 
1
 
 sensitive 
but cyclosporin insensitive.
Key words: apoptosis • mitochondria • Bax • cyto-
chrome C • permeability transition
 
T
 
he
 
 Bcl-2 gene family includes members which can
act as either inhibitors or activators of the apoptosis
process (Jacobson, 1997; Kroemer, 1997
 
a
 
; Reed,
1997). These proteins can form both homodimers as well
as selective pairs of heterodimers, and their ability to con-
trol cell death can be interdependent although it has been
shown that antiapoptotic and proapoptotic members can
also function independently (Knudson and Korsmeyer,
1997). Although the function of Bcl-2 proteins is not
clearly understood, it has been demonstrated that some of
them, including Bcl-x, Bcl-2, and Bax, can form ion chan-
nels in synthetic lipid membranes (Antonsson et al., 1997;
Minn et al., 1997; Schendel et al., 1997). Based on the crys-
tal structure of Bcl-X
 
L
 
, two central hydrophobic 
 
a
 
 helices
(
 
a
 
5 and 
 
a
 
6) reminiscent of the 
 
a
 
 helices which constitute
the pore-forming unit of colicins and diphtheria toxins
(Muchmore et al., 1996) are assumed to participate in the
pore-forming channel. The channels formed by Bcl-2 fam-
ily proteins can be described as multiconductance (con-
ductances larger than 1 nS have been reported for both
Bax and Bcl-2), pH-sensitive, voltage-gated channels with
a rather poor ion selectivity. Bcl-2 and Bcl-x channels are
rather cation selective, whereas Bax is anion selective at a
physiological pH (Antonsson et al., 1997; Minn et al., 1997;
Schendel et al., 1997; Schlesinger et al., 1997). Differences
in the amino acid composition of the 
 
a
 
5 and 
 
a
 
6 helices
could explain the distinct electrophysiological properties
of the channels formed by the pro- and antiapoptotic pro-
teins (Schlesinger et al., 1997).
Some Bcl-2 family members are associated with intra-
cellular membranes including the nuclear envelope, the
endoplasmic reticulum, and the outer mitochondrial mem-
brane. Membrane attachment is presumably due to a
hydrophobic amino acid sequence present at the COOH
terminus. Interestingly, Bax is specifically attached to mi-
tochondrial membranes (Zha et al., 1996; Hsu et al., 1997;
Wolter et al., 1997; Rosse et al., 1998) which may indicate
a role in the regulation of mitochondrial function during
apoptosis.
Mitochondria have been shown to play a key function in
the events leading to caspase activation in cell-free sys-
tems (Newmeyer et al., 1994) as well as in many cell types
undergoing apoptosis (Kroemer et al., 1997; Bossy-Wetzel
et al., 1998; Rosse et al., 1998). Induction of apoptosis is, in
some cells, associated with a loss of cytochrome C (Kroe-
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mer, 1997
 
b
 
; Kroemer et al., 1997; Bossy-Wetzel et al.,
1998) and possibly other mitochondrial proteins such as
apoptosis-inducing factor (AIF) (Zamzami et al., 1996). In
the cytosol, cytochrome C forms a complex with Apaf1, a
homologue of the 
 
Caenorhabditis
 
 
 
elegans
 
 protein ced-4,
and caspase 9, which triggers caspase activation and cell
death (Li et al., 1997).
It has been hypothesized that the leakage of cytochrome
C from the mitochondria into the cytosol, results from the
opening of a mitochondrial channel termed the permeabil-
ity transition pore (PTP)
 
1
 
 (Zamzami et al., 1995, 1996;
Marchetti et al., 1996; Kroemer, 1997
 
a
 
,
 
b
 
). The PTP func-
tions as a calcium-, voltage-, pH-, and redox-gated channel
with several levels of conductance (up to 1.3 nS), poor ion
selectivity, and allows the release of solutes with molecular
masses up to 1,500 Da (Zoratti and Szabo, 1995; Bernardi
and Petronilli, 1996; Ichas et al., 1997). The PTP is thought
to be composed of several proteins including hexokinase,
the voltage-dependent anion channel present on the outer
membrane, the inner membrane adenine nucleotide trans-
locator (ANT), and the matrix cyclophilin D (Zoratti and
Szabo, 1995; Nicolli et al., 1996; Bernardi and Petronilli,
1996; Beutner et al., 1996; Brustovetsky and Klingenberg,
1996; Halestrap et al., 1997). Importantly, Bax but not Bcl-2
or Bcl-x, was recently found to copurify with this complex
(Marzo et al., 1998). Moreover, Bax triggers the release of
cytochrome C from isolated mitochondria after overex-
pression in many cell types; however, how Bax triggers the
release of cytochrome C is still unknown (Xiang et al.,
1996; Manon et al., 1997; Juergensmeier et al., 1998; Pas-
torino et al., 1998; Rosse et al., 1998).
Here, we reconfirm that Bax can trigger the release of
cytochrome C after overexpression in different cell types
and directly when added to isolated mitochondria. The
Bax-induced release of cytochrome C is potentiated by
Mg
 
2
 
1
 
 ions and, in contrast to earlier findings, occurs inde-
pendently of the PTP both in intact cells and on isolated
mitochondria. 
 
Materials and Methods
 
Immunocytochemistry
 
HeLa cells were transfected with an expression vector (pCI; Promega
Corp., Madison, WI) containing His-Bax cDNA under the control of cy-
tomegalovirus
 
 
 
promoter using the Fugene-6 method (Boeringer Mann-
heim Biochemicals, Indianapolis, IN). Cells were fixed in 4% paraformal-
dehyde in PBS for 10 min and permeabilized in 0.2% Triton X-100 for 10
min at room temperature. After washing, the cells were incubated with
the appropriate antibodies in 5% normal goat serum. His tag was revealed
with a rabbit polyclonal antibody (Santa Cruz Biotechnology Inc., Santa
Cruz, CA) used at a 1:100 dilution. Cytochrome C was detected with a
mouse monoclonal antibody (PharMingen, San Diego, CA) used at a 1:20
dilution. Anti HSP-70 monoclonal antibody was used at 1:200 from Affin-
ity Bioagents Inc. (Golden, CO).
 
Mitochondrial Isolation
 
Before preparation the mice (female, strain 0F1, 10–25 wk) were starved
for 16 h. The liver was flushed with PBS and homogenized by hand in 60
ml mitochondrial buffer (MB) (210 mM mannitol, 70 mM sucrose, 10 mM
Hepes, pH 7.5, 1 mM EDTA) containing 0.45% BSA. The homogenate
was centrifuged for 6 min at 13,000 
 
g
 
. The pellet was dissolved in 30 ml
MB containing 0.45% BSA and centrifuged for 3 min at 1,400 
 
g 
 
and then
the supernatant was recentrifuged for 2 min at 13,000
 
 g
 
. The pellet was re-
suspended in 8 ml MB and 2 ml was layered on top of a discontinuous su-
crose gradient formed by layering 21 ml 1.2 M sucrose, 10 mM Hepes, pH
7.5, 1 mM EDTA, 0.1% BSA on top of 15 ml 1.6 M sucrose, 10 mM
Hepes, pH 7.5, 1 mM EDTA, 0.1% BSA. The samples were centrifuged at
27,000 rpm for 2 h in a Beckman SW28 rotor (Fullerton, CA) at 4
 
8
 
C. Mito-
chondria were recovered at the interface of 1.6 and 1.2 M sucrose, washed,
and then resuspended in MB containing 0.5 instead of 1 mM EDTA.
 
Cytochrome C Release Assay
 
His-tagged full-length human Bax was expressed in 
 
Escherichia
 
 
 
coli
 
 and
purified from the soluble cell fraction on Ni-NTA–agarose followed by
heparin and Mono Q FPLC sepharose. The purified protein was stored at
 
2
 
80
 
8
 
C in 25 mM Tris-HCl, 30% glycerol, 0.1 mM DTT, and 1% octyl glu-
coside, pH 7.5. This sample was diluted 100-fold in the assay buffer to give
a final concentration of 170 nM Bax. The mitochondria (100 
 
m
 
g protein)
were incubated for 1 h at 30
 
8
 
C in 200 
 
m
 
l KCl buffer (125 mM KCl, 0.5 mM
EGTA, 5 mM succinate, 10 mM Hepes-KOH, pH 7.4, 4 mM MgCl
 
2
 
, 5 mM
Na
 
2
 
HPO
 
4
 
, 5 
 
m
 
M Rotenon) or 200 ml MS buffer (210 mM mannitol, 70
mM sucrose, 10 mM Hepes-NaOH, pH 7.4, 0.5 mM EGTA, 5 mM succi-
nate, 5 
 
m
 
M Rotenon). The reaction mixtures were centrifuged at 13,000 
 
g
 
for 10 min at 4
 
8
 
C. Mitochondrial pellets corresponding to 5 
 
m
 
g mitochon-
drial proteins and corresponding supernatant fractions were subjected to
4–20% SDS-PAGE gel electrophoresis and analyzed by Western blotting
using a rabbit anti–cytochrome C serum. Equal loading of the mitochon-
drial pellet was controlled with a anti–Cox-VI antibody (Molecular
Probes Inc., Eugene, OR).
 
Results
 
Bax Triggers the Release of Cytochrome C After 
Overexpression in COS Cells
 
Immunofluorescence studies were designed to test whether
overexpression of Bax in HeLa cells could lead to the re-
lease of cytochrome C from mitochondria into the cytosol.
HeLa cells were transiently transfected with a DNA en-
coding a His-tagged Bax and immunostained with an anti-
His antibody 15 h later. Bax immunostaining appeared as
a punctuated staining (Fig. 1 
 
B
 
). A double immunostain-
ing using both an anti-Bax antibody and an antibody to
HSP-70, a mitochondrial marker (Fig. 1 
 
A
 
) revealed an
overlay of the two immunostainings demonstrating that,
after overexpression, Bax is strictly associated with mito-
chondria. Interestingly, although mitochondria appeared
filamentous in nontransfected cells, they were small,
round, and aggregated around the nucleus in Bax-overex-
pressing cells, suggesting that Bax modifies the shape as
well as the cellular location of mitochondria. A double im-
munostaining using anti-Bax and anti–cytochrome C anti-
bodies revealed that in 100% of the Bax-positive cells, a
diffuse cytosolic cytochrome C staining was observed whereas
Bax-immunonegative cells displayed a filamentous mito-
chondrial staining (observed in more than 10 experiments;
Fig. 2, 
 
A
 
 and 
 
B
 
). These data confirm previous results dem-
onstrating that after Bax overexpression, cytochrome C is
released from mitochondria into the cytosol (Manon et al.,
1998; Partorino et al., 1998; Rosse et al., 1998). Most of
these cells displayed a condensed apoptotic nucleus as in-
dicated by Hoechst staining (Fig. 2 
 
C
 
). Addition of the
caspase inhibitor z-VAD-fmk was able to prevent nuclear
condensation but could not inhibit Bax-induced cyto-
chrome C release, confirming that caspases are activated
downstream of cytochrome C release (Fig. 2, 
 
D
 
–
 
F
 
).
 
1. 
 
Abbreviations used in this paper
 
: BKA, bongkrekic acid; CsA, cy-
closporin A; MB, mitochondrial buffer; PTP, permeability transition pore;
PT, permeability. 
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Bax Induces the Release of Cytochrome C from
Isolated Mitochondria 
 
To establish whether the release of cytochrome C was a di-
rect or an indirect effect of Bax on the mitochondria, we
tested whether pure recombinant Bax alone was sufficient
to trigger the release of cytochrome C from freshly iso-
lated mouse liver mitochondria. Mitochondria energized
through complex II with succinate were incubated with
Figure 1. Mitochondrial localization of Bax.
HeLa cells were transiently transformed with
cDNA encoding a His-tagged Bax and immu-
nostained 15 h later for both the mitochondrial
marker HSP-70 (A) and Bax (B). Note that the
shape as well as the distribution of the mitochon-
dria has change in the Bax-transfected cell (ar-
row).
Figure 2. Immunofluorescence studies of cyto-
chrome C release from mitochondria after over-
expression of Bax in HeLa cells. HeLa cells were
transiently transfected with a cDNA encoding a
His-tagged human Bax and cultured for 15 h in
the presence (D–F) or absence (A–C) of z-VAD-
fmk before immunostaining for Bax (A and D)
and cytochrome C (B and E). C and F are nu-
clear Hoechst stainings. Arrows, transfected
cells. 
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170 nM full-length Bax, 5 
 
m
 
M Bcl-2
 
D
 
TM, or 5 
 
m
 
M
Bax
 
D
 
TM for 1 h (Bcl-2
 
D
 
TM and Bax
 
D
 
TM, both proteins
lacking the COOH-terminal hydrophilic domain, had been
shown to form ion channels in synthetic lipid membranes
 
[Antonsson et al., 1997; Schendel et al., 1997]). The cyto-
chrome C release was subsequently analyzed by Western
blotting of both the mitochondrial pellet and the superna-
tant (Fig. 3 
 
A
 
). Compared with the total amount of cyto-
chrome C contained within mitochondria recovered from
the sucrose gradient, we estimated that less than 5% of the
total amount of cytochrome C was released from un-
treated mitochondria after 1 h of incubation under the
conditions described above. In contrast, both Bax and
Bax
 
D
 
TM-treated mitochondria had lost 80–95% cyto-
chrome C. Such a release was obtained in 10 independent
experiments using three different Bax preparations. Full-
length Bax was estimated to be at least ten times more ef-
ficient than Bax
 
D
 
TM (data not shown). Similar results
were obtained when pyruvate and malate, instead of suc-
cinate, were used as a respiratory substrate (data not
shown).
 
Bax Triggers the Release of Cytochrome C from 
Mitochondria in a Dose- and Time-dependent Manner
 
The release of cytochrome C was dependent on the con-
centration of Bax protein, increasing from 5 to 170 nM
(Fig. 3 
 
C
 
). Kinetic experiments performed with 170 nM
Bax showed that the release of cytochrome C was already
detectable after 5 min of incubation and was almost com-
plete after 30 min (Fig. 3 
 
B
 
). Importantly, we noticed dur-
ing these experiments that the amount of Bax associated
with mitochondria remained constant between 5 and 60
min, suggesting that the binding of Bax to mitochondria is
a rapid and saturable process. It is of note that levels of en-
dogenous Bax in mouse liver mitochondria were low and
only weakly detectable by Western blotting. The amount
of Bax associated to mitochondria after adding 170 nM
during the different experiments was similar to the level of
endogenous Bax found on mitochondria isolated from
HeLa cells (data not shown). This finding indicates that
the Bax levels used in these studies were within the physi-
ological range.
 
Bax Effect Is Highly Potentiated by Mg
 
2
 
1
 
 Ions
 
Several ions were tested for their ability to influence Bax-
induced release of cytochrome C from mitochondria (Fig.
4). Sucrose and mannose were used to adjust the osmolar-
ity of all incubation buffers to 300–330 mOsm. Without the
addition of any salt, Bax failed to induce the release of cy-
tochrome C (Fig. 4, 
 
A 
 
and 
 
B
 
). However, under these con-
ditions the mitochondria are not respiring due to the lack
of ATP production that needs magnesium and phosphate.
Therefore, we added 4 mM MgCl
 
2
 
 and 5 mM Na
 
2
 
HPO
 
4
 
,
and now Bax was able to trigger 
 
.
 
90% cytochrome C re-
lease from the mitochondria (Fig. 4
 
 A
 
). Addition of MgCl
 
2
 
or Na
 
2
 
HPO
 
4
 
 separately showed that MgCl
 
2
 
 induced a
strong Bax effect (Fig. 4 
 
B
 
), indicating that the ions and
not the respiration were needed for the Bax effect. This
was further confirmed as Bax was not inhibited by antimy-
cin, a complex 3 inhibitor (data not shown). NaCl was inef-
fective demonstrating a key role for Mg
 
2
 
1
 
 ions in this ef-
fect (data not shown). As Mg
 
2
 
1
 
 ions have been reported to
inhibit the PTP (Zoratti and Szabo, 1995), these results
suggested that Bax and the PTP were two separate entities
Figure 3.  Bax-induced cytochrome C release from isolated mito-
chondria. (A) Mitochondria isolated from mouse liver were incu-
bated for 1 h at 308C with 5 mM COOH-terminal truncated Bax
(BaxDTM), 5 mM COOH-terminal truncated Bcl-2 or 170 nM
full-length Bax in 200 ml KCl buffer. After 1 h, the reaction mix-
ture was centrifuged at 13,000 g for 5 min. Supernatant and mito-
chondrial pellets corresponding to 5 mg mitochondrial proteins
were subjected to 4–20% SDS-PAGE and analyzed by Western
blot. Loading for the mitochondrial pellet was controlled with a
Cox IV antibody. (B) Kinetics of Bax-induced cytochrome C re-
lease. Mitochondria were incubated with 170 nM Bax or buffer
control at 308C and the mitochondria pellet was analysed over
time as in A. In addition to cytochrome C and Cox IV, Bax levels
were measured in the mitochondrial pellets. (C) Mitochondria
were incubated with different amounts of Bax for 1 h at 308C and
cytochrome C release was measured as in A. Data shown are rep-
resentative of 3–12 independent experiments performed with at
least three different preparations of Bax protein.Eskes et al. Bax Triggers Release of Cytochrome C from Mitochondria 221
and we therefore further tested this hypothesis using PTP
blockers.
Bax Triggers the Release of Cytochrome C from 
Mitochondria Independently of Several Components of 
the PTP
Opening of the PTP has been proposed to be involved in
the release of cytochrome C during apoptosis (Zamzami et
al., 1995,1996; Marchetti et al., 1996; Kroemer, 1997a).
Here, we confirmed that calcium, a known PTP opener,
triggers cytochrome C release from isolated mitochondria
as efficiently as Bax (Fig. 5 A) (Kantrow and Piantadosi,
1997). We then tested whether the Bax effect was medi-
ated through opening of the PTP by using inhibitors.
Blockers of the PTP including bongkrekic acid (BKA),
CsA, ADP, and EGTA were tested for their ability to in-
hibit Bax-induced release of cytochrome C from isolated
mitochondria. As shown in Fig. 5, none of these com-
pounds was able to block this Bax action. The combination
of CsA with the phospholipase A2 inhibitor arachistolic
acid (ARA), reported to act as a super-PTP inhibitor (Pas-
torino et al., 1998), also failed to inhibit the Bax effect. It is
of note that all these compounds were able to inhibit the
release of cytochrome C induced by the known PTP-
opener calcium (Fig. 5 A and data not shown).
PTP blockers were also tested for their ability to inhibit
the release of cytochrome C from mitochondria after over-
expression of Bax in COS cells (Fig. 6). COS cells cultured
Figure 4.  Bax effect is ion dependent. Mitochondria isolated
from mouse liver cells were incubated with 170 nM Bax at 308C in
sucrose-mannose buffer with or without addition of salts as indi-
cated in the figure. The salt concentrations were 4 mM MgCl2 and
5 mM Na2HPO4. Cytochrome C release was measured after 1 h as
described in Fig. 3.
Figure 5.  Bax-induced release of cytochrome C from isolated
mitochondria is not inhibited by PTP blockers. Several PTP
blockers have been tested for their ability to inhibit the release of
cytochrome C from isolated mitochondria induced by 170 nM
Bax. (A) We compared Bax effect with that of calcium, a PTP
opener, and their sensitivity to 10 mM CsA and 0.5 mM EGTA.
Cytochrome C and Cox IV in the mitochondrial pellet were mea-
sured after a 1-h incubation in KCl buffer at 308C by Western
blotting. The PTP inhibitors BKA (100 mM) (B), a combination
of CsA (10 mM) and ARA (50 mM) (C) and ADP (10 mM) (D)
were also tested. Mitochondria were preincubated with these
compounds for 5 min before addition of Bax. Note that although
CsA and EGTA were capable of inhibiting the calcium effect,
they failed to block Bax-induced cytochrome C release.The Journal of Cell Biology, Volume 143, 1998 222
in the presence of 10 mM cyclosporin A or 100 mM BKA
were transfected with Bax, and cytochrome C release was
analyzed 15 h later. These experiments were performed in
the presence of z-VAD-fmk to inhibit apoptosis induced
by cyclosporin A itself or by Bax. In three separate experi-
ments we found that 100% of the Bax-positive cells dis-
played a diffuse cytosolic cytochrome C staining. There-
fore, as found with isolated mitochondria, neither CsA nor
BKA were able to inhibit Bax-induced release of cyto-
chrome C in intact cells (Fig. 6).
Discussion
During apoptosis of many cell types, cytochrome C has
been shown to be released from mitochondria into the cy-
tosol, an event that leads to caspase activation (Kluck et
al., 1997; Yang et al., 1997; Li et al., 1997). Although the
mechanisms by which cytochrome C is released are not yet
understood, more and more evidence suggest that Bax, a
channel-forming protein localized on mitochondria, could
play a key role in this event. Here, we confirm that both
overexpressed Bax or purified Bax added to isolated mito-
chondria is sufficient to induce release of cytochrome C
(Vander Heiden et al., 1997; Rosse et al., 1998), suggesting
that Bax could be the component required for cytochrome
C release during apoptosis. The release of cytochrome C
has been attributed to opening of the PTP, a hypothesis
based on many data reporting that opening of the PTP re-
sults in Dcm collapse and leakage of many mitochondrial
proteins including cytochrome C (Kroemer, 1997a,b; Kroe-
mer et al., 1997; Marzo et al., 1998; Pastorino et al., 1998).
Furthermore Juergensmeier et al. (1998) claimed that cy-
closporin A was able to inhibit Bax-induced cytochrome C
release from isolated mitochondria. Our results are not in
agreement with such a hypothesis as we found that Bax-
induced release of cytochrome C from isolated mitochon-
dria could not be prevented by several PTP blockers, in-
cluding ADP, Mg21, cyclosporin A, and BKA. Differences
in the experimental procedures could explain these con-
flicting data. In the study of Juergensmeier et al. (1998),
mitochondria were incubated for 1 h in a buffer devoid of
calcium chelator whereas our experiments were per-
formed in a buffer containing 0.5 mM EGTA. EGTA was
used to prevent opening of the PTP by free calcium
present as traces in the used buffers. Indeed, we noticed
that in the absence of a calcium chelator, mitochondria
had a tendency to release spontaneously high levels of cy-
tochrome C (data not shown), an effect that was com-
pletely inhibited by EGTA. Interestingly, cyclosporin A
had a similar effect as EGTA. Therefore, we strongly be-
lieve that in the study of Juergensmeier et al. (1998), CsA
is not inhibiting Bax but rather the calcium-activated PTP.
We hypothesize that the Bax-induced release of cyto-
chrome C is accompanied by a leakage of calcium from the
mitochondria which, in absence of EGTA leads to calcium
cycling (Richter, 1993). This calcium cycling would result
in PTP opening of the least resistant mitochondria, since
mitochondria are not a homogeneous population (Ichas et
al., 1997). As these mitochondria undergo permeability
transition (PT) they release cytochrome C and calcium
into the buffer thereby further increasing the calcium con-
centration. This would induce more mitochondria to un-
Figure 6.  Both Cyclosporin A and BKA fail to
inhibit Bax-induced release of cytochrome C in
COS cells. COS cells were transfected with a
cDNA encoding His-Bax and cultured for 15 h in
the presence of 10 mM CsA and 100 mM z-VAD-
fmk (A and B) or 100 mM BKA and 100 mM
z-VAD-fmk (C and D) before immunostaining
for Bax (A and C) and cytochrome C (B and D).
Note that all cells that overexpress Bax display a
diffuse cytosolic cytochrome C immunostaining.
Arrows, transfected cells.Eskes et al. Bax Triggers Release of Cytochrome C from Mitochondria 223
dergo PT starting a positive feedback loop in a similar way
as described by Ichas et al. (1997). Thus by adding EGTA
to our incubation buffer, we were able to separate the Bax
effect from the PTP/calcium effect and therefore, this
strongly suggests that Bax acts on the mitochondria inde-
pendently of several components of the PTP.
Supporting our results obtained with isolated mitochon-
dria, we found that neither cyclosporin A nor BKA, a
long-term inhibitor of the PTP, were able to inhibit Bax-
induced cytochrome C release after overexpression in
COS cells. These results suggest that Bax triggers cyto-
chrome C release independently of at least two major
components of the PTP, cyclophilin D (cyclosporin A tar-
get), and the ANT (BKA target). These results, however,
do not eliminate the possibility that Bax could interact
with other components of the PTP as it was recently
shown that Bax copurifies with proteins participating in
the PTP complex (Marzo et al., 1998).
We have also demonstrated that Bax effect is highly de-
pendent on Mg21 ions. Among several functions, Mg21
ions stimulate ATP synthase activity and inhibit the F1-
ATPase in the presence of ADP (Boyer, 1997). Thus, it is
possible that Bax is active only when the ATP synthase is
stimulated, a hypothesis consistent with recent results by
Matsuyama et al. (1998) demonstrating a requirement for
the mitochondrial F0F1-ATPase proton pump for Bax
function in yeast and mammalian cells. How the mitochon-
drial proton pump activity could contribute to cytochrome
C release from mitochondria and Bax-killing activity is,
however, unknown. Recently, Bcl-2 was shown to prevent
loss of mitochondrial membrane potential, an early event
during apoptosis, by stimulating proton efflux (Shimizu et
al., 1998). One can hypothesize that both Bax and Bcl-2
act as proton channels: Bcl-2 allowing proton efflux
whereas Bax would stimulate proton influx, either di-
rectly, being itself a proton channel, or indirectly, through
the ATP synthase.
In conclusion, we have reported that Bax can trigger the
release of cytochrome C an event occurring early during
apoptosis, independently of the activity of the PTP. As a
working hypothesis, we propose that during apoptosis the
permeability of the mitochondrial membrane is not se-
verely affected, thereby allowing a specific release of a
small number of proteins as cytochrome C and possibly
AIF into the cytosol. In clear contrast, during necrosis, the
permeability of the mitochondrial membrane is severely
altered leading to the nonspecific release of proteins into
the cytosol, an event consistent with mitochondrial mem-
brane disruption (Vander Heiden et al., 1997).
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